FET-PET for Evaluation of Response of Recurrent GBM to Avastin
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to GBM
Related studies linked through entity extraction aliases.
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
PVSRIPO for Recurrent Glioblastoma (GBM)
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA
- Status
- COMPLETED
- Phase
- PHASE1
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE1
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
GW572016 to Treat Recurrent Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
- Status
- UNKNOWN
- Phase
- PHASE3